📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Activation of the Keap1/Nrf2 pathway suppresses mitochondrial dysfunction, oxidative stress, and motor phenotypes in C9orf72 ALS/FTD models. (2024)

First Author: Au WH

Attributed to: Identification of therapeutic targets in C9orf72-linked FTD and MND funded by UKRI Inn.Scholar

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202402853

PubMed Identifier: 38906677

Publication URI: http://europepmc.org/abstract/MED/38906677

Type: Journal Article/Review

Volume: 7

Parent Publication: Life science alliance

Issue: 9

ISSN: 2575-1077